Literature DB >> 6709114

Respiratory muscle weakness in uremic patients under continuous ambulatory peritoneal dialysis.

P Gómez-Fernández, L Sánchez Agudo, J M Calatrava, F Escuin, R Selgas, M E Martínez, A Montero, L Sánchez-Sicilia.   

Abstract

The increasingly frequent use of continuous ambulatory peritoneal dialysis (CAPD) as substitutive therapy in terminal renal failure has induced the investigation of the advantages and disadvantages of this therapeutic modality. The effects of CAPD on pulmonary function are one of the aspects currently under study. Based on previous data suggesting the existence of extrapulmonary ventilatory restriction in uremic patients under CAPD, we have studied in these patients the respiratory muscle function as expressed in the maximal inspiratory pressure (MIP) and assessed the impact of the infusion of 2 liters of dialysis fluid into the peritoneal cavity on both MIP and the pulmonary volumes. Uremic patients evidenced significantly lower MIP values as compared with healthy controls. The filling of the peritoneal cavity induced, both in the supine and in the sitting position, a restrictive effect and an increase in the inspiratory capacity. We conclude that uremic patients under CAPD evidence a respiratory muscle dysfunction of as yet unclear cause. Our findings further suggest that the infusion of 2 liters of dialysis fluid into the peritoneal cavity induces not only a restrictive effect, but also an increase in the strength of the respiratory muscles, the latter effect being probably due to increased diaphragmatic contractility.

Entities:  

Mesh:

Year:  1984        PMID: 6709114     DOI: 10.1159/000183157

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  10 in total

Review 1.  Peritoneal dialysis in acute kidney injury: Brazilian experience.

Authors:  Daniela Ponce; Jacqueline Teixeira Caramori; Pasqual Barretti; André Luís Balbi
Journal:  Perit Dial Int       Date:  2012 May-Jun       Impact factor: 1.756

2.  Pulmonary function in chronic renal failure: effects of dialysis and transplantation.

Authors:  A Bush; R Gabriel
Journal:  Thorax       Date:  1991-06       Impact factor: 9.139

Review 3.  Effect of uremia and its treatment on pulmonary function.

Authors:  D J Prezant
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Impact of peritoneal dialysis on pulmonary function test in a patient with diaphragm paralysis.

Authors:  Marie-Christine Simard-Meilleur; Claude Poirier; Jean Ethier
Journal:  Perit Dial Int       Date:  2015 Mar-Apr       Impact factor: 1.756

Review 5.  The lungs in uraemia: a review.

Authors:  A Bush; R Gabriel
Journal:  J R Soc Med       Date:  1985-10       Impact factor: 5.344

6.  Impact of continuous positive airway pressure (CPAP) on the respiratory capacity of chronic kidney disease patients under hemodialysis treatment.

Authors:  Vivian Bertoni Xavier; Renata Spósito Roxo; Luiz Antônio Miorin; Vera Lúcia Dos Santos Alves; Yvoty Alves Dos Santos Sens
Journal:  Int Urol Nephrol       Date:  2015-04-30       Impact factor: 2.370

Review 7.  When kidneys and lungs suffer together.

Authors:  Claudio Sorino; Nicola Scichilone; Claudio Pedone; Stefano Negri; Dina Visca; Antonio Spanevello
Journal:  J Nephrol       Date:  2018-12-06       Impact factor: 3.902

8.  Pulmonary function in children with chronic renal failure.

Authors:  K Paul; G Mavridis; K E Bonzel; K Schärer
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

9.  Diaphragmatic function in patients on continuous ambulatory peritoneal dialysis.

Authors:  T Wanke; M Auinger; H Lahrmann; M Merkle; D Formanek; K Irsigler; H Zwick
Journal:  Lung       Date:  1994       Impact factor: 2.584

10.  Respiratory muscle impairment in dialysis patients: can minimal dose of exercise limit the damage? A Preliminary study in a sample of patients enrolled in the EXCITE trial.

Authors:  Luca Pomidori; Nicola Lamberti; Anna Maria Malagoni; Fabio Manfredini; Enrico Pozzato; Michele Felisatti; Luigi Catizone; Antonio Barillà; Alessandro Zuccalà; Giovanni Tripepi; Francesca Mallamaci; Carmine Zoccali; Annalisa Cogo
Journal:  J Nephrol       Date:  2016-06-16       Impact factor: 3.902

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.